Benefit of oxaliplatin-based chemotherapy or capecitabine monotherapy in older patients with stage III and high-risk stage II colon cancer: Data from the National Colorectal Cancer Cohort study in China
Benefit of oxaliplatin-based chemotherapy or capecitabine monotherapy in older patients with stage III and high-risk stage II colon cancer: Data from the National Colorectal Cancer Cohort study in China
Wei Zhao, Ran Wei, Maiyue He, Zhaoxu Zheng et al.
Journal
Chinese Medical Journal
Topics
Colorectal Cancer Treatments and Studies
article
Benefit of oxaliplatin-based chemotherapy or capecitabine monotherapy in older patients with stage III and high-risk stage II colon cancer: Data from the National Colorectal Cancer Cohort study in China
Wei Zhao, Ran Wei, Maiyue He, Zhaoxu Zheng, Shiwen Mei, Fei Huang, Fangze Wei, Kexuan Li, Tixian Xiao, Qian Liu
article en
Abstract
No abstract available for this paper.
Publication Tag
Chinese Medical Journal
Institutions
Sun Yat-sen University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Benefit of oxaliplatin-based chemotherapy or capecitabine monotherapy in older patients with stage III and high-risk stage II colon cancer: Data from the National Colorectal Cancer Cohort study in China — Wei Zhao, Ran Wei, et al. · Chinese Medical Journal (2025) | TGRS Research Map | TGRS